Multi-journal partnership aims to accelerate scientific publishing by offering journal-independent peer review
Category: Press releases
MALT1 blockers have long been in clinical use for the treatment of blood cancers. A study suggests that these drugs could potentially also be developed as a treatment option for glioblastoma, the most common and lethal type of brain tumour.
EMBO Press is pleased to announce the appointment of systems biologist M. Madan Babu as the new Chief Editor of Molecular Systems Biology.
EMBO congratulates twenty-seven life scientists on their selection as new EMBO Young Investigators.
There are many indications that fasting promotes longevity. In recent years, much attention has been devoted to so-called caloric restriction mimetics (CMRs), substances that simulate the health-promoting effects of fasting without the need of life-style change.
Salaried employment, contributions to social security schemes, leadership training and networking
A multi-publisher partnership aims to streamline scientific publishing by producing refereed preprints